RxDoctor Payments Data

Alana Pringle, DO

Family Medicine · Newport News, VANPI 1770879686

Payments from drug & device makers

$5,757in general payments, 2019–2025

Across 343 payments — averaging $16.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$671
  • AstraZeneca$595
  • Pfizer$423
  • Amgen$396
  • Lilly USA, LLC$351
  • plus $2K from 38 others

What the payments were for

  • Food & beverage$5,70499%
  • Education$531%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,757 in reported general payments places this provider in the 85th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$200,126
Medicare patients
324
Services billed
5,699

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban60$55,544
TrulicityDulaglutide34$44,602
FarxigaDapagliflozin Propanediol24$28,585
OzempicSemaglutide13$24,954
LinzessLinaclotide20$22,445
JanuviaSitagliptin Phosphate17$21,934
XareltoRivaroxaban11$11,505
MounjaroTirzepatide11$9,804
Lantus SolostarInsulin Glargine,hum.Rec.Anlog31$8,051
Levothyroxine Sodium241$7,751
SynthroidLevothyroxine Sodium77$4,894
Rosuvastatin Calcium351$4,115
Solifenacin Succinate16$2,718
Atorvastatin Calcium343$2,677
ValacyclovirValacyclovir Hcl59$2,341

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$423$55,54460 claims
Lilly USA, LLCTrulicity, Mounjaro$351$54,40645 claims
AstraZenecaFarxiga$595$28,58524 claims
AbbVieLinzess, Synthroid$1,112$27,33997 claims
Novo NordiskOzempic$671$24,95413 claims
MerckJanuvia$41$21,93417 claims
Johnson & JohnsonXarelto$85$11,50511 claims
Almatica Pharma LLCSertraline Hcl$19$882114 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Newport News

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →